Page 303 - Read Online
P. 303
Page 16 of 18 Zimmermann et al. Vessel Plus 2019;3:31 I http://dx.doi.org/10.20517/2574-1209.2019.010
61. Nassif M, Abdelghani M, Bouma BJ, Straver B, Blom NA, et al. Historical developments of atrial septal defect closure devices: what
we learn from the past. Expert Rev Med Devices 2016;13:555-68.
62. Aytemir K, Oto A, Ozkutlu S, Canpolat U, Kaya EB, et al. Transcatheter interatrial septal defect closure in a large cohort: midterm
follow-up results. Congenit Heart Dis 2013;8:418-27.
63. Wang JK, Chiu SN, Lin MT, Chen CA, Lu CW, et al. Mid-to-long-term follow-up results of transcatheter closure of atrial septal defect
in patients older than 40 years. Heart vessels 2017;32:467-73.
64. Alnasser S, Lee D, Austin PC, Labos C, Osten M, et al. Long term outcomes among adults post transcatheter atrial septal defect closure:
Systematic review and meta-analysis. Int J Cardiol 2018;270:126-32.
65. Nicolay S, Salgado RA, Shivalkar B, Van Herck PL, Vrints C, et al. CT imaging features of atrioventricular shunts: what the radiologist
must know. Insights imaging 2016;7:119-29.
66. White HD, Halpern EJ, Savage MP. Imaging of adult atrial septal defects with CT angiography. JACC Cardiovasc Imaging
2013;6:1342-5.
67. Khoshpouri P, Khoshpouri P, Bedayat A, Ansari-Gilani K, Chalian H. Interatrial septum: A pictorial review of congenital and acquired
pathologies and their management. Clin Imaging 2019;55:53-64.
68. Song J, Kim Y, Aigerim T. Usefulness of cardiac computed tomography in transcatheter closure of atrial septal defect with amplatzer
septal occluder. Russ J of Cardiol 2013;47:35-9.
69. Chia RC, Salazar P, Al-Yafi M, Romano S, Farzaneh-Far A. Secundum Atrial Septal Defect. QJM 2018;111:571-2.
70. Lairakdomrong K, Srimahachota S, Lertsapcharoen P, Chaipromprasit J, Boonyaratavej S, et al. Clinical results of large secundum atrial
septal defect closure in adult using percutaneous transcatheter Cocoon atrial septal occluder. J Med Assoc Thai 2013;96:1127-34.
71. Thanopoulos BD, Biasco L, Dardas P, De Backer O, Avraamides P, et al. Catheter closure of atrial septal defects using the Cocoon
septal occluder: preliminary results of a European multicenter study. Int J Cardiol 2014;177:418-22.
72. Mijangos-Vázquez R, García-Montes AJ, Soto-López EM, Guarner-Lans V, Zabal C. Atrial septal defect closure with the new Cardia
Ultrasept II™ device with interposed Goretex patch: Mexican experience-has the perforation of Ivalon’s membrane been solved?
Cardiol Young 2018;28:709-14.
73. Bartel T, Bonaros N, Muller S. Device failure weeks to months after transcatheter closure of secundum type atrial septal defects. Heart
2010;96:1603.
74. Aubry P, Brochet E, du Fretay XH, Bouton-Brochet S, Ibrahim H, et al. Early malfunction of polyvinyl alcohol membrane-covered
atrial septal defect closure devices. Circ Cardiovasc Interv 2014;7:721-2.
75. Bozyel S, Sahin T, Dervis E, Aktas M, Saskin H. A massive left-to-right shunt due to delayed spontaneous perforation of polyvinyl
alcohol membrane of atrial septal occluder. Turk Kardiyol Dern Ars 2017;45:541-4.
76. Chamie F, Maia J, Giuliano LC. Device-in-device: a transcatheter alternative to surgical explantation of a failing atrial septal defect
intracardiac prosthesis. Catheter Cardiovasc Interv 2016;88:239-43.
77. Peirone A, Contreras A, Ferrero A, da Costa RN, Pedra SF, et al. Immediate and short-term outcomes after percutaneous atrial septal
defect closure using the new nit-occlud ASD-R device. Catheter Cardiovasc Interv 2014;84:464-70.
78. Bulut MO, Yucel IK, Kucuk M, Balli S, Basar EZ, et al. Initial experience with the Nit-Occlud ASD-R: short-term results. Pediatr
Cardiol 2016;37:1258-65.
79. Astarcioglu MA, Kalcik M, Sen T, Aykan AC, Gokdeniz T, et al. Ceraflex versus Amplatzer occluder for secundum atrial septal defect
closure. Multicenter clinical experience. Herz 2015;40 Suppl 2:146-50.
80. Apostolopoulou SC, Tsoutsinos A, Laskari C, Kiaffas M, Rammos S. Large single centre experience with the Cera and CeraFlex
occluders for closure of interatrial communications: usefulness of the flexible rotation feature. Cardiovasc Interv Ther 2018;33:70-6.
81. Kenny D, Eicken A, Dahnert I, Boudjemline Y, Sievert H, et al. A randomized, controlled, multi-center trial of the efficacy and safety of
the Occlutech Figulla Flex-II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal
defects. Catheter Cardiovasc Interv 2019;93:316-21.
82. Haas NA, Soetemann DB, Ates I, Baspinar O, Ditkivskyy I, et al. Closure of secundum atrial septal defects by using the occlutech
occluder devices in more than 1300 patients: the IRFACODE project: a retrospective case series. Catheter Cardiovasc Interv
2016;88:571-81.
83. Godart F, Houeijeh A, Recher M, Francart C, Polge AS, et al. Transcatheter closure of atrial septal defect with the Figulla® ASD
Occluder: a comparative study with the Amplatzer® Septal Occluder. Arch Cardiovasc Dis 2015;108:57-63.
84. Roymanee S, Promphan W, Tonklang N, Wongwaitaweewong K. Comparison of the Occlutech® Figulla® septal occluder and
Amplatzer® septal occluder for atrial septal defect device closure. Pediatr Cardiol 2015;36:935-41.
85. Kim AY, Jung SY, Chang JY, Jung JW, Choi JY. Early to mid-term follow-up outcomes of percutaneous closure of atrial septal defects
using recent generation devices: a single-center experience. Korean Circ J 2019;49:326-35.
86. O’Byrne ML, Glatz AC, Gillespie MJ. Transcatheter device closure of atrial septal defects: more to think about than just closing the
hole. Curr Opin Cardiol 2018;33:108-16.
87. de Hemptinne Q, Horlick EM, Osten MD, Millan X, Tadros VX, et al. Initial clinical experience with the GORE® CARDIOFORM
ASD occluder for transcatheter atrial septal defect closure. Catheter Cardiovasc Interv 2017;90:495-503.
88. Grohmann J, Wildberg C, Zartner P, Abu-Tair T, Tarusinov G, et al. Multicenter midterm follow-up results using the gore septal occluder
for atrial septal defect closure in pediatric patients. Catheter Cardiovasc Interv 2017;89:E226-32.
89. Turner DR, Owada CY, Sang CJ Jr, Khan M, Lim DS. Closure of secundum atrial septal defects with the AMPLATZER septal occluder: